ANVS earnings: a positive outcome, +14.1%

On May 4, 2022, Annovis Bio, Inc. reached its earnings. The result was a positive outcome, and the stock moved +14.1% in the window around the event. It had already run -31.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.